JP2023511616A5 - - Google Patents
Info
- Publication number
- JP2023511616A5 JP2023511616A5 JP2022545799A JP2022545799A JP2023511616A5 JP 2023511616 A5 JP2023511616 A5 JP 2023511616A5 JP 2022545799 A JP2022545799 A JP 2022545799A JP 2022545799 A JP2022545799 A JP 2022545799A JP 2023511616 A5 JP2023511616 A5 JP 2023511616A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20154031.7 | 2020-01-28 | ||
| EP20154031 | 2020-01-28 | ||
| PCT/EP2021/051697 WO2021151865A1 (en) | 2020-01-28 | 2021-01-26 | Modulators of the integrated stress response pathway |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023511616A JP2023511616A (ja) | 2023-03-20 |
| JP2023511616A5 true JP2023511616A5 (https=) | 2024-02-02 |
| JPWO2021151865A5 JPWO2021151865A5 (https=) | 2024-02-02 |
| JP7699595B2 JP7699595B2 (ja) | 2025-06-27 |
Family
ID=69374193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022545799A Active JP7699595B2 (ja) | 2020-01-28 | 2021-01-26 | 統合的ストレス応答経路の調節因子 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230125481A1 (https=) |
| EP (1) | EP4096665A1 (https=) |
| JP (1) | JP7699595B2 (https=) |
| KR (1) | KR20220133252A (https=) |
| CN (1) | CN114980894B (https=) |
| AU (1) | AU2021213289A1 (https=) |
| BR (1) | BR112022012643A2 (https=) |
| CA (1) | CA3162526A1 (https=) |
| IL (1) | IL294805A (https=) |
| MX (1) | MX2022009243A (https=) |
| WO (1) | WO2021151865A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201245B (zh) | 2017-09-01 | 2024-04-05 | 戴纳立制药公司 | 化合物、组合物和方法 |
| SG11202108552QA (en) * | 2019-02-13 | 2021-09-29 | Denali Therapeutics Inc | Compounds, compositions and methods |
| EP3924341A4 (en) | 2019-02-13 | 2022-11-02 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| CN115190813B (zh) | 2020-03-11 | 2024-10-15 | 埃沃特克国际有限责任公司 | 整合应激反应途径的调节剂 |
| EP4232153A1 (en) | 2020-10-22 | 2023-08-30 | Evotec International GmbH | Modulators of the integrated stress response pathway |
| RS66455B1 (sr) | 2020-10-22 | 2025-02-28 | Evotec Int Gmbh | Modulatori puta integrisanog odgovora na stres |
| EP4232447A1 (en) | 2020-10-22 | 2023-08-30 | Evotec International GmbH | Modulators of the integrated stress response pathway |
| AU2023384649A1 (en) * | 2022-11-21 | 2025-05-22 | Shenzhen Zhongge Biological Technology Co., Ltd. | Compound, pharmaceutical composition containing same, synthesis method therefor and use thereof |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4033412A1 (de) | 1990-10-20 | 1992-04-23 | Bayer Ag | Fungizide mittel auf basis von heterocyclisch substituierten sulfonen |
| CA2904794C (en) | 2013-03-15 | 2021-11-23 | Peter Walter | Modulators of the eif2alpha pathway |
| SG11201605757SA (en) * | 2013-12-20 | 2016-08-30 | Inst Drug Discovery | Substituted amino triazoles, and methods using same |
| TW201808888A (zh) | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TWI763668B (zh) | 2016-05-05 | 2022-05-11 | 美商嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TW201808914A (zh) | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TW201808903A (zh) | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| KR20190015492A (ko) | 2016-06-08 | 2019-02-13 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 화학적 화합물 |
| US20190298705A1 (en) | 2016-06-08 | 2019-10-03 | Glaxosmithkline Intellectual Property Development Limited | Chemical Compounds |
| WO2018225093A1 (en) | 2017-06-07 | 2018-12-13 | Glaxosmithkline Intellectual Property Development Limited | Chemical compounds as atf4 pathway inhibitors |
| EP3649108A1 (en) | 2017-07-03 | 2020-05-13 | GlaxoSmithKline Intellectual Property Development Limited | 2-(4-chlorophenoxy)-n-((1 -(2-(4-chlorophenoxy)ethynazetidin-3-yl)methyl)acetamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseases |
| BR112020000122A2 (pt) | 2017-07-03 | 2020-07-07 | Glaxosmithkline Intellectual Property Development Limited | derivados da n-(3-(2-(4-clorofenóxi)acetamido)biciclo[1.1.1] pentan-1-il)-2-ciclobutano-1-carboxamida e compostos relacionados como inibidores do atf4 para tratamento contra o câncer e outras doenças |
| CA3071024A1 (en) | 2017-08-09 | 2019-02-14 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| CN111201245B (zh) | 2017-09-01 | 2024-04-05 | 戴纳立制药公司 | 化合物、组合物和方法 |
| WO2019090090A1 (en) | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| WO2019090074A1 (en) | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| UY37958A (es) | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| WO2019090088A1 (en) | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| CA3080808A1 (en) | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| UY37956A (es) | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| JP2021501781A (ja) | 2017-11-02 | 2021-01-21 | カリコ ライフ サイエンシーズ エルエルシー | 統合的ストレス経路の調節剤 |
| UY37957A (es) | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| AU2018358157B2 (en) | 2017-11-02 | 2023-03-09 | Abbvie Inc. | Modulators of the integrated stress pathway |
| CN111757739A (zh) | 2017-12-13 | 2020-10-09 | 普拉西斯生物技术有限责任公司 | 整合应激反应路径抑制剂 |
| WO2019183589A1 (en) | 2018-03-23 | 2019-09-26 | Denali Therapeutics Inc. | Modulators of eukaryotic initiation factor 2 |
| WO2019193540A1 (en) | 2018-04-06 | 2019-10-10 | Glaxosmithkline Intellectual Property Development Limited | Heteroaryl derivatives of formula (i) as atf4 inhibitors |
| WO2019193541A1 (en) | 2018-04-06 | 2019-10-10 | Glaxosmithkline Intellectual Property Development Limited | Bicyclic aromatic ring derivatives of formula (i) as atf4 inhibitors |
-
2021
- 2021-01-26 JP JP2022545799A patent/JP7699595B2/ja active Active
- 2021-01-26 KR KR1020227029412A patent/KR20220133252A/ko active Pending
- 2021-01-26 EP EP21702218.5A patent/EP4096665A1/en active Pending
- 2021-01-26 IL IL294805A patent/IL294805A/en unknown
- 2021-01-26 CN CN202180011613.3A patent/CN114980894B/zh active Active
- 2021-01-26 AU AU2021213289A patent/AU2021213289A1/en active Pending
- 2021-01-26 US US17/759,490 patent/US20230125481A1/en active Pending
- 2021-01-26 CA CA3162526A patent/CA3162526A1/en active Pending
- 2021-01-26 WO PCT/EP2021/051697 patent/WO2021151865A1/en not_active Ceased
- 2021-01-26 MX MX2022009243A patent/MX2022009243A/es unknown
- 2021-01-26 BR BR112022012643A patent/BR112022012643A2/pt unknown